Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
4/2020 due to acquisition
RDD Pharma
RDD Pharma Overview
RDD Pharma is a specialty drugcompanydeveloping targeted pharmacological treatments for diseases of the anorectal region, such as anal fissures, fecal incontinence, and pruritus ani. A pharmaceutical compound targeting radiation proctitis is also in preclinical development.
The company focuses on finding new uses for existing drugs. By choosing medications that are already approved for other indications and combining them with aproprietary drug-delivery technology, RDDbenefits from a short regulatory route while maintaining patent protection.
RDD recently completed a successful phase-2a study of RDD 0315 in fecal incontinence, which reached the primary endpoint (lowered frequency of incontinence events). The company is also initiating a phase-3 study for treatment of chronic anal fissure with RDD 1219.
RDD Pharma Climate Tech relevance
undefined
Companies you might be interested in
Driven by Finder AI
Latest News
No Data, yet.
Sorry, no content found under this section.
Oct 29, 2019
www.beckersasc.com
The story behind the Innovate, RDD merger
#Acquisition #Management Changes
Oct 10, 2019
en.globes.co.il
Israel's RDD Pharma merges with Innovate Biopharmaceuticals
#Acquisition #Investment
Feb 14, 2019
www.prnewswire.com
RDD Pharma Receives Fast Track Designation from FDA for RDD-0315 for Treatment of Fecal Incontinence in Spinal Cord Injury Patients
#Customers
Jul 17, 2018
www.prnewswire.com
RDD Pharma Announces IND Clearance to Advance RDD-0315 to Treat Fecal Incontinence in Patients with Spinal Cord Injury
#Customers
Nov 16, 2017
www.prnewswire.com
RDD Pharma Raises $9.5M in Series B Funding to Fuel Global Development